TY - JOUR
T1 - ACR Appropriateness Criteria ® Staging and Follow-Up of Ovarian Cancer
AU - Expert Panel on Women's Imaging:
AU - Kang, Stella K.
AU - Reinhold, Caroline
AU - Atri, Mostafa
AU - Benson, Carol B.
AU - Bhosale, Priyadarshani R.
AU - Jhingran, Anuja
AU - Lakhman, Yulia
AU - Maturen, Katherine E.
AU - Nicola, Refky
AU - Pandharipande, Pari V.
AU - Salazar, Gloria M.
AU - Shipp, Thomas D.
AU - Simpson, Lynn
AU - Small, William
AU - Sussman, Betsy L.
AU - Uyeda, Jennifer W.
AU - Wall, Darci J.
AU - Whitcomb, Bradford P.
AU - Zelop, Carolyn M.
AU - Glanc, Phyllis
N1 - Publisher Copyright:
© 2018 American College of Radiology
PY - 2018/5
Y1 - 2018/5
N2 - In the management of epithelial ovarian cancers, imaging is used for cancer detection and staging, both before and after initial treatment. The decision of whether to pursue initial cytoreductive surgery for ovarian cancer depends in part on accurate staging. Contrast-enhanced CT of the abdomen and pelvis (and chest where indicated) is the current imaging modality of choice for the initial staging evaluation of ovarian cancer. Fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT and MRI may be appropriate for problem-solving purposes, particularly when lesions are present on CT but considered indeterminate. In patients who achieve remission, clinical suspicion for relapse after treatment prompts imaging evaluation for recurrence. Contrast-enhanced CT is the modality of choice to assess the extent of recurrent disease, and fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT is also usually appropriate, as small metastatic foci may be identified. If imaging or clinical examination confirms a recurrence, the extent of disease and timing of disease recurrence then determines the choice of treatments, including surgery, chemotherapy, and radiation therapy. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
AB - In the management of epithelial ovarian cancers, imaging is used for cancer detection and staging, both before and after initial treatment. The decision of whether to pursue initial cytoreductive surgery for ovarian cancer depends in part on accurate staging. Contrast-enhanced CT of the abdomen and pelvis (and chest where indicated) is the current imaging modality of choice for the initial staging evaluation of ovarian cancer. Fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT and MRI may be appropriate for problem-solving purposes, particularly when lesions are present on CT but considered indeterminate. In patients who achieve remission, clinical suspicion for relapse after treatment prompts imaging evaluation for recurrence. Contrast-enhanced CT is the modality of choice to assess the extent of recurrent disease, and fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT is also usually appropriate, as small metastatic foci may be identified. If imaging or clinical examination confirms a recurrence, the extent of disease and timing of disease recurrence then determines the choice of treatments, including surgery, chemotherapy, and radiation therapy. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
KW - AUC
KW - Appropriate Use Criteria
KW - Appropriateness Criteria
KW - Imaging evaluation
KW - Ovarian cancer
KW - Recurrence
KW - Staging
UR - http://www.scopus.com/inward/record.url?scp=85046978149&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046978149&partnerID=8YFLogxK
U2 - 10.1016/j.jacr.2018.03.015
DO - 10.1016/j.jacr.2018.03.015
M3 - Article
C2 - 29724422
AN - SCOPUS:85046978149
SN - 1546-1440
VL - 15
SP - S198-S207
JO - Journal of the American College of Radiology
JF - Journal of the American College of Radiology
IS - 5
ER -